Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy

Viviana Carillo, Cesare Cozzarini, Andreina Chietera, Lucia Perna, Stefano Gianolini, Angelo Maggio, Andrea Botti, Tiziana Rancati, Riccardo Valdagni, Claudio Fiorino

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The correlation between bladder dose-wall-histogram (DWH) and dose-volume-histogram (DVH), dose-surface-histogram (DSH), and DVH-5/10 was investigated in a group of 28 patients; bladder walls were drawn on T2-MRI. DVH showed the poorest correlation with DWH; DSH or DVH-5/10 should be preferred in planning; absolute DVH may be used for radical patients, although less robust.

Original languageEnglish
Pages (from-to)180-183
Number of pages4
JournalRadiotherapy and Oncology
Volume105
Issue number2
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Prostatic Neoplasms
Urinary Bladder
Radiotherapy

Keywords

  • Bladder wall
  • Dose surface histogram
  • GU toxicity
  • Prostate radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy. / Carillo, Viviana; Cozzarini, Cesare; Chietera, Andreina; Perna, Lucia; Gianolini, Stefano; Maggio, Angelo; Botti, Andrea; Rancati, Tiziana; Valdagni, Riccardo; Fiorino, Claudio.

In: Radiotherapy and Oncology, Vol. 105, No. 2, 11.2012, p. 180-183.

Research output: Contribution to journalArticle

@article{8b40f3f0a6d4479aaebe492f820962ce,
title = "Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy",
abstract = "The correlation between bladder dose-wall-histogram (DWH) and dose-volume-histogram (DVH), dose-surface-histogram (DSH), and DVH-5/10 was investigated in a group of 28 patients; bladder walls were drawn on T2-MRI. DVH showed the poorest correlation with DWH; DSH or DVH-5/10 should be preferred in planning; absolute DVH may be used for radical patients, although less robust.",
keywords = "Bladder wall, Dose surface histogram, GU toxicity, Prostate radiotherapy",
author = "Viviana Carillo and Cesare Cozzarini and Andreina Chietera and Lucia Perna and Stefano Gianolini and Angelo Maggio and Andrea Botti and Tiziana Rancati and Riccardo Valdagni and Claudio Fiorino",
year = "2012",
month = "11",
doi = "10.1016/j.radonc.2012.10.001",
language = "English",
volume = "105",
pages = "180--183",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy

AU - Carillo, Viviana

AU - Cozzarini, Cesare

AU - Chietera, Andreina

AU - Perna, Lucia

AU - Gianolini, Stefano

AU - Maggio, Angelo

AU - Botti, Andrea

AU - Rancati, Tiziana

AU - Valdagni, Riccardo

AU - Fiorino, Claudio

PY - 2012/11

Y1 - 2012/11

N2 - The correlation between bladder dose-wall-histogram (DWH) and dose-volume-histogram (DVH), dose-surface-histogram (DSH), and DVH-5/10 was investigated in a group of 28 patients; bladder walls were drawn on T2-MRI. DVH showed the poorest correlation with DWH; DSH or DVH-5/10 should be preferred in planning; absolute DVH may be used for radical patients, although less robust.

AB - The correlation between bladder dose-wall-histogram (DWH) and dose-volume-histogram (DVH), dose-surface-histogram (DSH), and DVH-5/10 was investigated in a group of 28 patients; bladder walls were drawn on T2-MRI. DVH showed the poorest correlation with DWH; DSH or DVH-5/10 should be preferred in planning; absolute DVH may be used for radical patients, although less robust.

KW - Bladder wall

KW - Dose surface histogram

KW - GU toxicity

KW - Prostate radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84871277782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871277782&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2012.10.001

DO - 10.1016/j.radonc.2012.10.001

M3 - Article

C2 - 23182056

AN - SCOPUS:84871277782

VL - 105

SP - 180

EP - 183

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -